136 related articles for article (PubMed ID: 34114045)
21. Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.
Doğan B; Demir H; Işık N; Gunalp G; Günbey HP; Yaprak G
Br J Radiol; 2024 May; 97(1157):1022-1028. PubMed ID: 38426391
[TBL] [Abstract][Full Text] [Related]
22. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
23. Border Zone Maybe Correlated with Radiation Necrosis After Radiosurgery in Metastatic Brain Tumor.
Lee C; Yoon SY; Hwang JH; Park SH; Kwon M; Yoon C; Lee K; Hahm MH; Park KS
World Neurosurg; 2024 Mar; ():. PubMed ID: 38561029
[TBL] [Abstract][Full Text] [Related]
24. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.
Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956
[TBL] [Abstract][Full Text] [Related]
25. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
26. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
27. Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy.
Burke AM; Carrasquilla M; Jean WC; Collins BT; Anaizi AN; Atkins MB; Gibney GT; Collins SP
Front Oncol; 2021; 11():794615. PubMed ID: 35096594
[TBL] [Abstract][Full Text] [Related]
28. Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma.
Thomson HM; Fortin Ensign SP; Edmonds VS; Sharma A; Butterfield RJ; Schild SE; Ashman JB; Zimmerman RS; Patel NP; Bryce AH; Vora SA; Sio TT; Porter AB
Clin Med Insights Oncol; 2023; 17():11795549231161878. PubMed ID: 36968334
[TBL] [Abstract][Full Text] [Related]
29. Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases.
Terakedis BE; Jensen RL; Boucher K; Shrieve DC
J Radiosurg SBRT; 2014; 3(1):21-28. PubMed ID: 29296381
[TBL] [Abstract][Full Text] [Related]
30. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
31. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.
Sayan M; Şahin B; Mustafayev TZ; Kefelioğlu EŞS; Vergalasova I; Gupta A; Balmuk A; Güngör G; Ohri N; Weiner J; Karaarslan E; Özyar E; Atalar B
Neurocirugia (Astur : Engl Ed); 2020 Oct; ():. PubMed ID: 33082103
[TBL] [Abstract][Full Text] [Related]
32. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
[TBL] [Abstract][Full Text] [Related]
33. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
34. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery.
Kowalchuk RO; Niranjan A; Lee CC; Yang HC; Liscak R; Guseynova K; Tripathi M; Kumar N; Peker S; Samanci Y; Hess J; Chiang V; Iorio-Morin C; Mathieu D; Pikis S; Wei Z; Lunsford LD; Trifiletti DM; Sheehan JP
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):726-734. PubMed ID: 34644606
[TBL] [Abstract][Full Text] [Related]
36. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract][Full Text] [Related]
37. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
38. A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.
Soler DC; Kerstetter-Fogle A; Elder T; Raghavan A; Barnholtz-Sloan JS; Cooper KD; McCormick TS; Sloan AE
Neurosurgery; 2020 Dec; 88(1):E67-E72. PubMed ID: 32823285
[TBL] [Abstract][Full Text] [Related]
39. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
[TBL] [Abstract][Full Text] [Related]
40. Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.
Telera S; Fabi A; Pace A; Vidiri A; Anelli V; Carapella CM; Marucci L; Crispo F; Sperduti I; Pompili A
J Neurooncol; 2013 Jun; 113(2):313-25. PubMed ID: 23525948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
